Yoshiharu Maeda

Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

M. Emi, Yutaka Fujiwara, Takashi Nakajima et al. · PubMed · 1992 · 270 citations

Cytogenetics, Genetics, Pathology +16

Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

Rei Kikuchi-Yanoshita, Motoko Konishi, Sadayoshi Ito et al. · PubMed · 1992 · 183 citations

Colorectal Adenoma, Cancer Pathology, Genetics +16

Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Michiko Miyaki, Makoto Seki, Mitsumasa Okamoto et al. · PubMed · 1990 · 178 citations

Cancer Pathology, Moderate Adenomas, Genetics +19

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential

Hiroshi Iino, Masashi Fukayama, Yoshiharu Maeda et al. · Cancer · 1994 · 106 citations · Full text